AstraZeneca Aktie
144,20
EUR
-1,90
EUR
-1,30
%
125,26
GBP
-0,38
GBP
-0,30
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Diese Analysten bewerten die AstraZeneca-Aktie
Analyst | Kursziel | Abstand Kursziel | Datum | |
---|---|---|---|---|
JP Morgan Chase & Co. | 140,00 GBP | - | 20.10.2025 | |
Deutsche Bank AG | 105,00 GBP | - | 16.10.2025 | |
UBS AG | 142,00 GBP | - | 13.10.2025 | |
Bernstein Research | 180,00 GBP | - | 07.10.2025 | |
Goldman Sachs Group Inc. | 151,63 GBP | - | 02.10.2025 | |
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 142,00 GBP | - | 17.09.2025 | |
Jefferies & Company Inc. | 109,00 GBP | - | 29.07.2025 | |
DZ BANK | - | - | 30.04.2025 |
Werbung
Kursziele im Branchenvergleich
Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
---|---|---|---|---|---|
Abbott Laboratories | 0 | 0 | 0 | - | - |
Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
APONTIS PHARMA | 0 | 0 | 0 | - | - |
AstraZeneca PLC | 5 | 2 | 1 | 138,52 GBP | - |
Bayer | 2 | 7 | 0 | 26,81 EUR | -2,72% |
BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +25,36% |
CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
Celgene Corp. | 0 | 0 | 0 | - | - |
CureVac | 0 | 1 | 0 | - | - |
EVOTEC SE | 2 | 2 | 0 | 8,42 EUR | +26,58% |
Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
Johnson & Johnson | 0 | 0 | 0 | - | - |
Merck Co. | 0 | 0 | 0 | - | - |
Merck KGaA | 6 | 2 | 0 | 148,71 EUR | +30,79% |
Moderna Inc | 0 | 1 | 0 | 42,00 USD | +54,19% |
Novartis AG | 3 | 4 | 2 | 98,25 CHF | -5,98% |
Novavax Inc. | 0 | 0 | 0 | - | - |
Pfizer Inc. | 3 | 4 | 0 | 29,33 USD | +18,79% |
Roche AG (Genussschein) | 3 | 2 | 3 | 276,00 CHF | -1,50% |
Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
Sanofi S.A. | 8 | 1 | 0 | 109,50 EUR | +26,60% |
Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
STADA | 0 | 0 | 0 | - | - |
Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
Valneva | 0 | 0 | 0 | - | - |
Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
Warner Chilcott plc | 0 | 0 | 0 | - | - |